Lung Diseases Cies Search Engine [selected websites]

Loading

Blog Archive

Mar 14, 2008

Novelos Therapeutics, Pivotal Phase 3 Lung Cancer Trial

March 13, 2008 - -Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos has reached the target enrollment of 840 patients in the pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) for its lead product NOV-002 in combination with first-line chemotherapy... [PDF] Novelos' Press Release -